spacer
spacer

PDBsum entry 1m0e

Go to PDB code: 
protein dna_rna ligands links
Transferase/DNA PDB id
1m0e

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
327 a.a. *
DNA/RNA
Ligands
SAH
Waters ×245
* Residue conservation analysis
PDB id:
1m0e
Name: Transferase/DNA
Title: Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferase
Structure: 5'-d(p Cp Cp Ap Tp Gp Cp Gp Cp Tp Gp Ap C)-3'. Chain: c. Engineered: yes. 5'-d(p Gp Tp Cp Ap Gp (Z)p Gp Cp Ap Tp Gp G)-3'. Chain: d. Engineered: yes. Modification methylase hhai. Chain: a. Synonym: cytosine-specific methyltransferase hhai, m.Hhai.
Source: Synthetic: yes. Haemophilus haemolyticus. Organism_taxid: 726. Expressed in: escherichia coli. Expression_system_taxid: 562
Biol. unit: Nonamer (from PQS)
Resolution:
2.50Å     R-factor:   0.177     R-free:   0.243
Authors: L.Zhou,X.Cheng,B.A.Connolly,M.J.Dickman,P.J.Hurd,D.P.Hornby
Key ref:
L.Zhou et al. (2002). Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases. J Mol Biol, 321, 591-599. PubMed id: 12206775 DOI: 10.1016/S0022-2836(02)00676-9
Date:
12-Jun-02     Release date:   18-Sep-02    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P05102  (MTH1_HAEPH) -  Type II methyltransferase M.HhaI from Haemophilus parahaemolyticus
Seq:
Struc:
327 a.a.
327 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

DNA/RNA chains
  C-C-A-T-G-C-G-C-T-G-A-C 12 bases
  G-T-C-A-G-__Z-G-C-A-T-G-G 12 bases

 Enzyme reactions 
   Enzyme class: E.C.2.1.1.37  - Dna (cytosine-5-)-methyltransferase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: a 2'-deoxycytidine in DNA + S-adenosyl-L-methionine = a 5-methyl- 2'-deoxycytidine in DNA + S-adenosyl-L-homocysteine + H+
2'-deoxycytidine in DNA
+ S-adenosyl-L-methionine
= 5-methyl- 2'-deoxycytidine in DNA
Bound ligand (Het Group name = SAH)
corresponds exactly
+ S-adenosyl-L-homocysteine
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1016/S0022-2836(02)00676-9 J Mol Biol 321:591-599 (2002)
PubMed id: 12206775  
 
 
Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases.
L.Zhou, X.Cheng, B.A.Connolly, M.J.Dickman, P.J.Hurd, D.P.Hornby.
 
  ABSTRACT  
 
Mechanism-based inhibitors of enzymes, which mimic reactive intermediates in the reaction pathway, have been deployed extensively in the analysis of metabolic pathways and as candidate drugs. The inhibition of cytosine-[C5]-specific DNA methyltransferases (C5 MTases) by oligodeoxynucleotides containing 5-azadeoxycytidine (AzadC) and 5-fluorodeoxycytidine (FdC) provides a well-documented example of mechanism-based inhibition of enzymes central to nucleic acid metabolism. Here, we describe the interaction between the C5 MTase from Haemophilus haemolyticus (M.HhaI) and an oligodeoxynucleotide duplex containing 2-H pyrimidinone, an analogue often referred to as zebularine and known to give rise to high-affinity complexes with MTases. X-ray crystallography has demonstrated the formation of a covalent bond between M.HhaI and the 2-H pyrimidinone-containing oligodeoxynucleotide. This observation enables a comparison between the mechanisms of action of 2-H pyrimidinone with other mechanism-based inhibitors such as FdC. This novel complex provides a molecular explanation for the mechanism of action of the anti-cancer drug zebularine.
 
  Selected figure(s)  
 
Figure 1.
Figure 1. The reaction pathway of C5 MTases in the presence and in the absence of mechanism-based inhibitors. (a) The reaction pathway for all C5 MTases involves the transfer of the labile methyl group from S-adenosyl- Image -methionine (AdoMet) to the 5 position of the cytosine ring, proceeds through a covalent intermediate at position C6.[14] The nucleophilic attack upon the C6 position of cytosine drives the subsequent acquisition of the labile methyl group from AdoMet. (Note, the protonation status of Glu119 in M.HhaI[36]). (b) The inhibition by FdC. Following covalent complex formation and methyl transfer, the analogue remains bound to the active-site Cys, since abstraction of F cannot be achieved. (c) The inhibition by AzaC. Following covalent complex formation at a C6 with enhanced reactivity, slow methyl transfer may take place, but there is no H at C5 to abstract and the covalent complex persists. (d) The inhibition by zebularine. Following covalent complex formation at a C6 with enhanced reactivity as with AzaC, facilitated deamination at C4 cannot proceed, [33] since the amino moiety is absent from the analogue. Note that the water molecule nearest to the C4 atom is 3.6 Å away and the water molecule nearest to the C5 atom is 3.3 Å away.
Figure 2.
Figure 2. Structure of M.HhaI-AdoHcy-DNA containing zebularine. (a) The structural impasse between the proposed mechanism (outlined in Figure 1) and the barrier to substrate access in duplex DNA was overcome elegantly by the phenomenon of protein-induced base flipping. [15] Once the target base (zebularine here) is released from the constraints of the Watson-Crick base-pair, conventional active-site chemistry is facilitated. (b) Zebularine difference electron density maps (F[o] -F[c], a[c]) superimposed on the refined coordinates with carbon atoms being yellow, oxygen atoms red, nitrogen atom blue, and sulfur atom green, respectively. The blue electron density map contoured at 5.0s was computed with the zebularine moiety omitted from the atomic model. The green electron density maps contoured above 5.5s were calculated with the C4, C5, and C6 atoms of zebularine omitted from the atomic model, respectively. The zebularine is constrained in the plane of the ring by a highly conserved network of hydrogen bonds (via E119 and R165) and van der Waals interactions between the main-chain C=O group of F79 and C4 and C5 atoms. (c) A view perpendicular to (b), looking edge-on at the flipped zebularine molecule. A covalent bond is observed between C6 of the zebularine ring and an invariant thiolate side-chain C81, approaching the C6 perpendicular to the ring. The red electron density map contoured above 10.0s was calculated with the sulfur atom of C81 omitted from the atomic model.
 
  The above figures are reprinted by permission from Elsevier: J Mol Biol (2002, 321, 591-599) copyright 2002.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21417907 A.S.Alva, N.M.Hahn, A.M.Aparicio, R.Singal, S.Yellapragada, and G.Sonpavde (2011).
Hypomethylating agents for urologic cancers.
  Future Oncol, 7, 447-463.  
21345368 J.Ren, B.N.Singh, Q.Huang, Z.Li, Y.Gao, P.Mishra, Y.L.Hwa, J.Li, S.C.Dowdy, and S.W.Jiang (2011).
DNA hypermethylation as a chemotherapy target.
  Cell Signal, 23, 1082-1093.  
21320002 T.Robak (2011).
New nucleoside analogs for patients with hematological malignancies.
  Expert Opin Investig Drugs, 20, 343-359.  
20005183 B.Betham, S.Shalhout, V.E.Marquez, and A.S.Bhagwat (2010).
Use of Drosophila deoxynucleoside kinase to study mechanism of toxicity and mutagenicity of deoxycytidine analogs in Escherichia coli.
  DNA Repair (Amst), 9, 153-160.  
20808780 C.Champion, D.Guianvarc'h, C.Sénamaud-Beaufort, R.Z.Jurkowska, A.Jeltsch, L.Ponger, P.B.Arimondo, and A.L.Guieysse-Peugeot (2010).
Mechanistic insights on the inhibition of c5 DNA methyltransferases by zebularine.
  PLoS One, 5, e12388.  
20442312 J.C.Chuang, S.L.Warner, D.Vollmer, H.Vankayalapati, S.Redkar, D.J.Bearss, X.Qiu, C.B.Yoo, and P.A.Jones (2010).
S110, a 5-Aza-2'-deoxycytidine-containing dinucleotide, is an effective DNA methylation inhibitor in vivo and can reduce tumor growth.
  Mol Cancer Ther, 9, 1443-1450.  
20436342 K.Sebova, and I.Fridrichova (2010).
Epigenetic tools in potential anticancer therapy.
  Anticancer Drugs, 21, 565-577.  
20701443 L.Maldonado, and M.O.Hoque (2010).
Epigenomics and ovarian carcinoma.
  Biomark Med, 4, 543-570.  
  19856314 M.Pandey, S.Shukla, and S.Gupta (2010).
Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells.
  Int J Cancer, 126, 2520-2533.  
21077830 N.A.Cherepanova, A.L.Zhuze, and E.S.Gromova (2010).
Inhibition of murine DNA methyltransferase Dnmt3a by DNA duplexes containing pyrimidine-2(1H)-one.
  Biochemistry (Mosc), 75, 1115-1125.  
20097869 T.Baubec, H.Q.Dinh, A.Pecinka, B.Rakic, W.Rozhon, B.Wohlrab, A.von Haeseler, and O.Mittelsten Scheid (2010).
Cooperation of multiple chromatin modifications can generate unanticipated stability of epigenetic States in Arabidopsis.
  Plant Cell, 22, 34-47.  
20059740 Y.Iwase, T.Shiraya, and K.Takeno (2010).
Flowering and dwarfism induced by DNA demethylation in Pharbitis nil.
  Physiol Plant, 139, 118-127.  
19381297 A.Pecinka, M.Rosa, A.Schikora, M.Berlinger, H.Hirt, C.Luschnig, and O.Mittelsten Scheid (2009).
Transgenerational stress memory is not a general response in Arabidopsis.
  PLoS ONE, 4, e5202.  
19467223 D.M.van Bemmel, A.S.Brank, R.Eritja, V.E.Marquez, and J.K.Christman (2009).
DNA (Cytosine-C5) methyltransferase inhibition by oligodeoxyribonucleotides containing 2-(1H)-pyrimidinone (zebularine aglycon) at the enzymatic target site.
  Biochem Pharmacol, 78, 633-641.  
19641188 G.Lal, and J.S.Bromberg (2009).
Epigenetic mechanisms of regulation of Foxp3 expression.
  Blood, 114, 3727-3735.  
18398609 M.Lemaire, L.F.Momparler, N.J.Raynal, M.L.Bernstein, and R.L.Momparler (2009).
Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.
  Cancer Chemother Pharmacol, 63, 411-416.  
19916931 O.V.Kirsanova, N.A.Cherepanova, and E.S.Gromova (2009).
Inhibition of C5-cytosine-DNA-methyltransferases.
  Biochemistry (Mosc), 74, 1175-1186.  
18684339 R.Thaler, H.Karlic, P.Rust, and A.G.Haslberger (2009).
Epigenetic regulation of human buccal mucosa mitochondrial superoxide dismutase gene expression by diet.
  Br J Nutr, 101, 743-749.  
19222038 S.Warncke, A.Gégout, and T.Carell (2009).
Phosphorothioation of oligonucleotides strongly influences the inhibition of bacterial (M.HhaI) and human (Dnmt1) DNA methyltransferases.
  Chembiochem, 10, 728-734.  
18826433 T.Baubec, A.Pecinka, W.Rozhon, and O.Mittelsten Scheid (2009).
Effective, homogeneous and transient interference with cytosine methylation in plant genomic DNA by zebularine.
  Plant J, 57, 542-554.  
19006382 C.B.Yoo, R.Valente, C.Congiatu, F.Gavazza, A.Angel, M.A.Siddiqui, P.A.Jones, C.McGuigan, and V.E.Marquez (2008).
Activation of p16 gene silenced by DNA methylation in cancer cells by phosphoramidate derivatives of 2'-deoxyzebularine.
  J Med Chem, 51, 7593-7601.  
17883328 C.Ptak, and A.Petronis (2008).
Epigenetics and complex disease: from etiology to new therapeutics.
  Annu Rev Pharmacol Toxicol, 48, 257-276.  
17991895 S.S.Palii, B.O.Van Emburgh, U.T.Sankpal, K.D.Brown, and K.D.Robertson (2008).
DNA methylation inhibitor 5-Aza-2'-deoxycytidine induces reversible genome-wide DNA damage that is distinctly influenced by DNA methyltransferases 1 and 3B.
  Mol Cell Biol, 28, 752-771.  
18196590 S.Veerla, I.Panagopoulos, Y.Jin, D.Lindgren, and M.Höglund (2008).
Promoter analysis of epigenetically controlled genes in bladder cancer.
  Genes Chromosomes Cancer, 47, 368-378.  
17507378 D.J.Baker, G.Wuenschell, L.Xia, J.Termini, S.E.Bates, A.D.Riggs, and T.R.O'Connor (2007).
Nucleotide excision repair eliminates unique DNA-protein cross-links from mammalian cells.
  J Biol Chem, 282, 22592-22604.  
17895890 E.M.Hurt, S.B.Thomas, B.Peng, and W.L.Farrar (2007).
Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines.
  Br J Cancer, 97, 1116-1123.  
17458893 L.Sigalotti, E.Fratta, S.Coral, E.Cortini, A.Covre, H.J.Nicolay, L.Anzalone, L.Pezzani, A.M.Di Giacomo, E.Fonsatti, F.Colizzi, M.Altomonte, L.Calabrò, and M.Maio (2007).
Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
  J Cell Physiol, 212, 330-344.  
17214905 S.P.Rao, M.P.Rechsteiner, C.Berger, J.A.Sigrist, D.Nadal, and M.Bernasconi (2007).
Zebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells.
  Mol Cancer, 6, 3.  
17464245 T.E.Fandy, H.Carraway, and S.D.Gore (2007).
DNA demethylating agents and histone deacetylase inhibitors in hematologic malignancies.
  Cancer J, 13, 40-48.  
16485345 C.B.Yoo, and P.A.Jones (2006).
Epigenetic therapy of cancer: past, present and future.
  Nat Rev Drug Discov, 5, 37-50.  
16807237 G.Le Gac, P.O.Estève, C.Ferec, and S.Pradhan (2006).
DNA damage-induced down-regulation of human Cdc25C and Cdc2 is mediated by cooperation between p53 and maintenance DNA (cytosine-5) methyltransferase 1.
  J Biol Chem, 281, 24161-24170.  
16460559 I.M.Adcock, P.Ford, P.J.Barnes, and K.Ito (2006).
Epigenetics and airways disease.
  Respir Res, 7, 21.  
16965942 Q.Lu, X.Qiu, N.Hu, H.Wen, Y.Su, and B.C.Richardson (2006).
Epigenetics, disease, and therapeutic interventions.
  Ageing Res Rev, 5, 449-467.  
16234563 F.Lyko, and R.Brown (2005).
DNA methyltransferase inhibitors and the development of epigenetic cancer therapies.
  J Natl Cancer Inst, 97, 1498-1506.  
15895087 J.C.Meier, C.Henneberger, I.Melnick, C.Racca, R.J.Harvey, U.Heinemann, V.Schmieden, and R.Grantyn (2005).
RNA editing produces glycine receptor alpha3(P185L), resulting in high agonist potency.
  Nat Neurosci, 8, 736-744.  
15898057 M.Biel, V.Wascholowski, and A.Giannis (2005).
Epigenetics--an epicenter of gene regulation: histones and histone-modifying enzymes.
  Angew Chem Int Ed Engl, 44, 3186-3216.  
15164071 G.Egger, G.Liang, A.Aparicio, and P.A.Jones (2004).
Epigenetics in human disease and prospects for epigenetic therapy.
  Nature, 429, 457-463.  
15324698 J.C.Cheng, C.B.Yoo, D.J.Weisenberger, J.Chuang, C.Wozniak, G.Liang, V.E.Marquez, S.Greer, T.F.Orntoft, T.Thykjaer, and P.A.Jones (2004).
Preferential response of cancer cells to zebularine.
  Cancer Cell, 6, 151-158.  
14729971 J.C.Cheng, D.J.Weisenberger, F.A.Gonzales, G.Liang, G.L.Xu, Y.G.Hu, V.E.Marquez, and P.A.Jones (2004).
Continuous zebularine treatment effectively sustains demethylation in human bladder cancer cells.
  Mol Cell Biol, 24, 1270-1278.  
15182354 O.M.Subach, A.V.Khoroshaev, D.N.Gerasimov, V.B.Baskunov, A.K.Shchyolkina, and E.S.Gromova (2004).
2-Pyrimidinone as a probe for studying the EcoRII DNA methyltransferase-substrate interaction.
  Eur J Biochem, 271, 2391-2399.  
15270655 R.Brown, and J.A.Plumb (2004).
Demethylation of DNA by decitabine in cancer chemotherapy.
  Expert Rev Anticancer Ther, 4, 501-510.  
12618505 J.C.Cheng, C.B.Matsen, F.A.Gonzales, W.Ye, S.Greer, V.E.Marquez, P.A.Jones, and E.U.Selker (2003).
Inhibition of DNA methylation and reactivation of silenced genes by zebularine.
  J Natl Cancer Inst, 95, 399-409.  
14751833 V.E.Marquez, R.Eritja, J.A.Kelley, D.Vanbemmel, and J.K.Christman (2003).
Potent inhibition of HhaI DNA methylase by the aglycon of 2-(1H)-pyrimidinone riboside (zebularine) at the GCGC recognition domain.
  Ann N Y Acad Sci, 1002, 154-164.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer